Community

What OEM Buyers in Photonics Actually Evaluate During Vendor Selection

October 28, 2026 - Marco Pigozzi

OEM evaluations in photonics are long, technically demanding, and involve buying committees of six to twelve people with different objectives. Most vendors focus on the technical evaluation and underinvest in the commercial process. This article presents a three-phase, 14-question framework — built from 15 years of experience in photonics and precision instrumentation markets — that helps suppliers understand what buyers are actually assessing beyond the specification sheet. A cost-of-inaction model is included to make the commercial stakes concrete.



Introduction

A photonics component vendor who has completed a successful technical evaluation — good data, validated performance, enthusiastic R&D feedback — and still lost the deal is not failing at the technical stage. They are failing at the commercial stage.

This distinction matters because the photonics industry invests heavily in technical excellence and comparatively little in commercial process. The assumption, often implicit, is that a technically superior product will win. In practice, the buying decision in an OEM evaluation involves multiple stakeholders with different objectives, a procurement process that introduces its own logic, and a risk framework that is often invisible to the supplier until it becomes decisive.

The framework presented here is not theoretical. It reflects patterns observed across more than fifteen years of OEM sales in photonics and precision optics markets — patterns consistent enough to be systematic, and specific enough to be actionable.

The Context: Why Photonics OEM Evaluations Are Different

Most B2B sales methodologies were designed for cycles measured in weeks or months. A photonics OEM evaluation typically runs from eighteen months to three years, involves a buying committee of six to twelve people with different functions and different risk tolerances, and results in a component specification that will stay in production for seven to ten years.

These characteristics create a set of commercial dynamics that generic sales training does not address:

• The technical evaluator and the commercial decision-maker are rarely the same person, and their criteria are often in tension.

• The switching cost of changing a component after design-in is extremely high — which means the buyer is making a strategic supplier relationship decision, not just a product selection.

• The procurement process in a regulated or precision-manufacturing context adds a qualification burden that can take longer than the technical evaluation itself.

• The “invisible veto holder” — the person who can block a decision that everyone else supports — is a recurring feature of large OEM buying committees and is almost never visible to the supplier until late in the process.

Understanding what buyers are evaluating at each stage of this process is the first condition of commercial effectiveness in this market.

The Three-Phase Evaluation Framework

The following framework organises the buyer’s actual evaluation logic into three phases, each with specific questions that a supplier who is commercially prepared should be able to answer. These questions are not the supplier’s questions — they are the buyer’s questions, surfaced through observation of how decisions are actually made.

Phase 1: Before the Pilot — Strategic Fit and Supplier Profile

Before a formal evaluation begins, the buyer is assessing whether engaging with this supplier is worth the organisational investment. This phase is often invisible to the supplier, but it is where many evaluations are effectively decided.

The questions the buyer is working through in this phase:

1. Is this component technically necessary for what we are building, or is it a nice-to-have? Can we solve this problem with something we already qualify?

2. Is this supplier commercially viable as a long-term partner — financially stable, with a credible supply chain for the production volumes we will eventually need?

3. Does this supplier understand our application? Have they worked in our vertical before, and do they have reference customers in comparable use cases?

4. What is the integration burden? How much engineering resource will we need to commit to the evaluation, and is the supplier’s application support capable of reducing that burden?

5. What is our fallback if this relationship does not work out? Is there an alternative supplier we could qualify if needed?

The implication for suppliers: the first conversations in a photonics OEM evaluation are not product conversations. They are supplier credibility conversations. A supplier who leads with technical specifications before establishing their commercial profile and application expertise is answering questions the buyer has not yet asked.

Practitioner note: The most common mistake at Phase 1 is treating the first technical contact — typically an R&D engineer or applications scientist — as the evaluator. They are the technical evaluator, but they are rarely the decision-maker. The question “who else will be involved in this decision?” should be asked explicitly in the first substantive meeting.

Phase 2: During the Evaluation — Technical and Commercial Parallel Tracks

The formal evaluation phase involves two tracks running simultaneously. The supplier typically sees the technical track. The commercial track — running inside the buyer’s organisation — is often entirely invisible to the supplier and is where most deals stall or fail.

On the technical track, the buyer is assessing:

6. Does the component meet the performance specification under real operating conditions — not just in the vendor’s application note?

7. What is the integration complexity? How much re-engineering of our system does this component require, and what risks does that introduce?

8. What is the reliability data? MTBF, environmental testing, lifetime under our specific duty cycle — not generic datasheet figures?

On the commercial track, the buyer is simultaneously working through a different set of questions:

9. Has this supplier been formally assessed by our procurement team? Are they on our approved vendor list, or what is the qualification path?

10. What are the commercial terms — lead times, MOQ, pricing at production volumes, warranty, liability — and are they within our procurement framework?

11. What is the risk to our programme if this supplier has a supply chain disruption? Do they have geographic concentration risk or single-source components?

The critical insight here is that the commercial track has its own decision-makers — procurement, operations, legal — who typically enter the evaluation later than the technical evaluators but whose concerns are no less significant. A supplier who has managed only the technical relationship will encounter these stakeholders at the commercial stage without any established relationship or credibility.

Practitioner note: The best indicator that a deal is progressing commercially — not just technically — is when the buyer’s champion introduces you to someone outside R&D without you having asked for the introduction. A champion who has not done this by the time the pilot results are positive is a champion who has not yet started the internal commercial process.

Phase 3: Before Commercial Negotiation — Risk and Decision Process

The final phase before a purchase order is issued is when the Risk Owner — the person inside the buyer’s organisation who bears the consequence if the supplier relationship fails — makes their assessment. This person is often not visible during the technical evaluation, and their concerns are different in character from both the technical evaluator’s and the procurement team’s.

12. What happens to our product and our production schedule if this supplier cannot deliver? What is our contingency?

13. Who in our organisation is accountable for this decision, and are they confident in the risk profile?

14. What is the internal business case for selecting this supplier rather than an alternative — and is our champion capable of making that case to the people whose approval we need?

This last question is the one that most suppliers never address directly. The internal business case — the argument that the buyer’s champion needs to make to their colleagues, to their manager, and to the final approver — is almost never a technical argument. It is a risk argument, and it needs to be constructed with the supplier’s help if the champion is to be effective.

The Cost of Commercial Inaction: Making the Stakes Concrete

The framework above identifies what buyers are evaluating. What it does not make explicit is what it costs a supplier — in revenue, in time, and in opportunity — to remain commercially unprepared in long-cycle OEM markets.

The following model is deliberately illustrative, not prescriptive. The inputs vary significantly by market, product category, and deal size. The structure, however, is consistent across the OEM deals I have observed in this industry.

Illustrative Cost-of-Inaction Model — Photonics OEM Deal

Assumptions:

  • Component unit price: €2,500   |   Annual volume at production: 800 units

  • Design-in lifetime: 8 years    |   Annual contract value: €2,000,000

  • Evaluation cycle: 24 months    |   Probability of win (commercially prepared): 55%

  • Probability of win (technical only): 25%

Cost of one year of commercial delay (deal stalls at technical stage):

  → Revenue deferred: €2,000,000

  → Internal sales cost (account manager + application engineer): ~€180,000/year

  → Opportunity cost (resources not deployed elsewhere): €300,000–500,000

Incremental value of closing this deal vs. losing it:

  → 8-year contract value: €16,000,000

  → Win-rate delta (commercial vs. technical-only): +30 percentage points

  → Expected value gain from commercial preparation: €4,800,000 per deal

Three dynamics make this model conservative rather than aggressive in most photonics OEM contexts.

First, the design-in lock-in effect means that a won deal does not generate revenue for one contract period — it generates revenue for as long as the buyer’s product is in production. In markets like scientific instrumentation, semiconductor equipment, or defence optics, that can be fifteen to twenty years. The true lifetime value of an OEM design-in is rarely reflected in a single contract calculation.

Second, the cost of a lost evaluation is not just the lost revenue from that specific deal. A competitor who wins the design-in acquires a reference customer in your target application — a reference that will be cited in every subsequent evaluation in that vertical. In markets where reference selling is the primary commercial mechanism, a lost design-in has compounding consequences.

Third, the internal cost of carrying a stalled evaluation is higher than most sales organisations acknowledge. A senior application engineer committed to a twelve-month pilot that is not progressing commercially is not available for early-stage development work with higher-probability opportunities. The opportunity cost is real even when it is not measured.

The practical implication is straightforward: the commercial work described in this article — stakeholder mapping, champion development, internal business case construction — is not an overhead on the technical evaluation. It is the activity that determines whether the technical evaluation results in a purchase order or a polite “we have decided to go in a different direction.”

Self-assessment: For each active OEM evaluation in your pipeline, ask: “If this deal does not close, what is the 8-year revenue impact — and what is the one commercial gap most likely to cause that outcome?” If you cannot answer the second question specifically, the gap analysis in Phase 2 of this framework is the right starting point.

Commercial Implications for Photonics Vendors

The framework above has several direct implications for how photonics component suppliers approach OEM evaluations.

First, stakeholder mapping should begin at the first meeting, not at the commercial stage.

Identifying the Technical Authority, the Commercial Gatekeeper, the Risk Owner, and the Champion — and understanding their individual concerns — is not a one-time exercise. It is an ongoing intelligence-gathering process that shapes every interaction in the evaluation.

Second, the application engineering relationship has commercial value that is systematically under-leveraged. The supplier who is fastest to respond to integration challenges, most proactive in sharing relevant data, and most technically credible in the buyer’s application context is building a commercial advantage that competitors cannot easily displace.

Third, supporting the internal business case is a commercial activity, not a marketing one. This means understanding what the Risk Owner’s specific concern is, providing the right data and framing in the right format at the right time — not producing a generic presentation that the champion may not be able to use effectively in an internal conversation.

Finally, the commercial process in a photonics OEM evaluation is not separable from the technical process. They run in parallel, involve different people, and have different logic. Treating the technical evaluation as the evaluation is the structural error that produces the outcome described at the beginning of this article: a successful pilot and a lost deal.

Conclusion

Photonics OEM markets reward technical excellence — but they do not award purchase orders on that basis alone. The vendors who consistently win evaluations in this market are those who understand the full buying process: who is involved, what each person is managing, and what the buyer needs at each stage to advance the decision internally.

The 14 questions in this framework are a diagnostic tool. A supplier who can answer all of them — with specific, evidence-based answers — for an active evaluation is commercially prepared. A supplier who cannot answer several of them has identified where the risk in their pipeline actually lies.

The cost-of-inaction model makes the stakes concrete. In a market where a single OEM design-in can generate eight-figure revenue over its lifetime, the investment required to build commercial competence alongside technical excellence is not a cost — it is the highest-return activity available to a photonics component vendor.

About the Author

Marco Pigozzi is a commercial leader with fifteen years of experience in deep-tech B2B OEM markets, specialising in photonics, optical systems, and precision instrumentation. He has led sales and marketing organisations across photonics, machine vision, medical, and scientific instrumentation markets, and has spoken on commercial strategy at industry events including the EMVA Business Conference.

Privacy Overview

This website uses cookies so that we can give you the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team understand which sections of the website you find most interesting and useful.

For more information, visit our privacy policy page